In past decades, studies indicated that the ATRA can alleviate the fibrosis in pulmonary fibrosis [25], diabetic nephropathy [1,26], etc. In our studies, we found that ATRA can reduce the RIF index and down-regulate the protein expressions of Col-IV, FN and TGF-β1. This evidence concerns the gene FN1 and diabetic kidney disease.